A hypothesis and theoretical model speculating the possible role of therapy mediated neoplastic cell loss in promoting the process of glioblastoma relapse - PubMed (original) (raw)
. 2010 Oct 21;266(4):496-503.
doi: 10.1016/j.jtbi.2010.07.009. Epub 2010 Jul 22.
Affiliations
- PMID: 20655317
- DOI: 10.1016/j.jtbi.2010.07.009
A hypothesis and theoretical model speculating the possible role of therapy mediated neoplastic cell loss in promoting the process of glioblastoma relapse
Mrinmay Kumar Mallik. J Theor Biol. 2010.
Abstract
Tumor recurrence is considered to be one of the biggest culprits, behind the poor prognosis of glioblastomas. Using published facts on primary glioblastomas, with special reference to cancer stem cells and their recently described heterogeneity, a hypothesis is being proposed that speculates the possible role of therapy mediated neoplastic cell loss in promoting the process of relapse in these tumors. The mechanisms by which such a phenomenon could be functional has been integrated into a double version theoretical model, which envisages glioblastomas as neoplasms comprising of multiple, differentially regulated and dynamically distinct neoplastic compartments (named as active and back-up compartments in this article) supported by their own complement of cancer stem cells, wherein therapy mediated cell loss, which mainly affects the size of the active compartment, results in abrogating the inhibitory effect of the active compartment on the back-up compartment, thereby leading to the activation of the back-up compartment. This activation contributes towards tumor recurrence. The possibility of the existence of such a phenomenon could have strong implications on management and prognosis of these tumors. This article aims to provoke discussion and generate new ideas for further research.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
- Cancer stem cells and glioma.
Das S, Srikanth M, Kessler JA. Das S, et al. Nat Clin Pract Neurol. 2008 Aug;4(8):427-35. doi: 10.1038/ncpneuro0862. Epub 2008 Jul 15. Nat Clin Pract Neurol. 2008. PMID: 18628751 Review. - IQGAP1 protein specifies amplifying cancer cells in glioblastoma multiforme.
Balenci L, Clarke ID, Dirks PB, Assard N, Ducray F, Jouvet A, Belin MF, Honnorat J, Baudier J. Balenci L, et al. Cancer Res. 2006 Sep 15;66(18):9074-82. doi: 10.1158/0008-5472.CAN-06-0761. Cancer Res. 2006. PMID: 16982749 - Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
Shiras A, Chettiar ST, Shepal V, Rajendran G, Prasad GR, Shastry P. Shiras A, et al. Stem Cells. 2007 Jun;25(6):1478-89. doi: 10.1634/stemcells.2006-0585. Epub 2007 Mar 1. Stem Cells. 2007. PMID: 17332509 - Brain tumor stem cells as research and treatment targets.
Hide T, Takezaki T, Nakamura H, Kuratsu J, Kondo T. Hide T, et al. Brain Tumor Pathol. 2008;25(2):67-72. doi: 10.1007/s10014-008-0237-5. Epub 2008 Nov 6. Brain Tumor Pathol. 2008. PMID: 18987831 Review.
Cited by
- Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research.
Aktipis CA, Kwan VS, Johnson KA, Neuberg SL, Maley CC. Aktipis CA, et al. PLoS One. 2011;6(11):e26100. doi: 10.1371/journal.pone.0026100. Epub 2011 Nov 17. PLoS One. 2011. PMID: 22125594 Free PMC article.